Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats.
about
Basal Ganglia circuits underlying the pathophysiology of levodopa-induced dyskinesia.Unilateral 6-hydroxydopamine lesion of dopamine neurons and subchronic L-DOPA administration in the adult rat alters the expression of the vesicular GABA transporter in different subsets of striatal neurons and in the substantia nigra, pars reticulaTime-course of SKF-81297-induced increase in glutamic acid decarboxylase 65 and 67 mRNA levels in striatonigral neurons and decrease in GABA(A) receptor alpha1 subunit mRNA levels in the substantia nigra, pars reticulata, in adult rats with a unilatEffects of 5-HT1A receptor stimulation on D1 receptor agonist-induced striatonigral activity and dyskinesia in hemiparkinsonian rats.Role of movement in long-term basal ganglia changes: implications for abnormal motor responses.Metabotropic glutamate mGluR5 receptor blockade opposes abnormal involuntary movements and the increases in glutamic acid decarboxylase mRNA levels induced by l-DOPA in striatal neurons of 6-hydroxydopamine-lesioned rats.Antisense gene silencing: therapy for neurodegenerative disorders?Adenosine A2A Receptor Gene Knockout Prevents l-3,4-Dihydroxyphenylalanine-Induced Dyskinesia by Downregulation of Striatal GAD67 in 6-OHDA-Lesioned Parkinson's Mice.Knockdown of GAD67 protein levels normalizes neuronal activity in a rat model of Parkinson's disease.Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse.Does MPTP intoxication in mice induce metabolite changes in the nucleus accumbens? A ¹H nuclear MRS study.Metabolic changes detected by ex vivo high resolution 1H NMR spectroscopy in the striatum of 6-OHDA-induced Parkinson's rat.Potentiation of amphetamine-mediated responses in caffeine-sensitized rats involves modifications in A2A receptors and zif-268 mRNAs in striatal neurons.
P2860
Q34165820-9C992790-AA6E-4167-A8CD-E3FF9893EE4EQ35846784-576CB4C1-50CD-4EF4-A157-416A804DFD63Q36791342-7C64EE74-1AD1-4406-A8D3-6567E7375090Q36851672-D6C122ED-F1A6-4F5D-84D9-56670F267DD0Q37249385-CCBE8633-8F81-49F0-B02F-A3FDA50876E6Q37384351-CD11F732-4494-4792-92DE-E011D2C1B1D1Q37585001-5AEF683D-8037-4458-83ED-0ABAC5BD6547Q37712460-1676693D-2704-48CC-B91D-E7D889E5EF12Q39568396-DAFC7877-2920-4461-A385-D918AAD924D3Q46844307-0E58B5FB-6AAC-4F78-9617-0FD236525D0EQ48339373-3565436B-8657-4557-9A25-A19E4B082E9DQ48393298-D04A9F5D-5781-4D6F-8E6F-D07E1534E35EQ48498126-5995006D-780C-444B-8A28-2D879140BF18
P2860
Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Selective modifications in GAD ...... hydroxydopamine-lesioned rats.
@en
Selective modifications in GAD ...... hydroxydopamine-lesioned rats.
@nl
type
label
Selective modifications in GAD ...... hydroxydopamine-lesioned rats.
@en
Selective modifications in GAD ...... hydroxydopamine-lesioned rats.
@nl
prefLabel
Selective modifications in GAD ...... hydroxydopamine-lesioned rats.
@en
Selective modifications in GAD ...... hydroxydopamine-lesioned rats.
@nl
P2093
P2860
P1476
Selective modifications in GAD ...... -hydroxydopamine-lesioned rats
@en
P2093
P2860
P304
P356
10.1046/J.1460-9568.2003.02983.X
P407
P577
2003-11-01T00:00:00Z